PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Crude extracts and isolated compounds act as inhibitors of biofilm formation [PMID: 32087316]
Ethanolic leaf extract (250 mg/kg) produced a reduction in gastric lesions and inflammatory enzyme activities [PMID: 38435992]
Daily oral dose of 250 mg/kg showed chemopreventive efficacy by reducing colon tumors and aberrant crypt foci [PMID: 30923945, 34435594]
Leaf extract and phytosomes reduced oxidative stress and inflammation in the liver, heart, and brain [PMID: 39456515, 40867573]
Leaf extracts and isolated meroterpenoids exhibit preferential cytotoxicity against cells under nutrient starvation [PMID: 32631550, 32573227]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32087316 (2020) — Callistemon citrinus bioactive metabolites as new inhibitors of methicillin-resistant Staphylococcus aureus biofilm formation. · Journal of ethnopharmacology
- 2.PMID: 39456515 (2024) — Role of Callistemon citrinus Leaf Phytosomes Against Oxidative Stress and Inflammation in Rats Fed with a High-Fat-Fructose Diet. · Antioxidants (Basel, Switzerland)
- 3.PMID: 38435992 (2024) — Use of Callistemon citrinus as a gastroprotective and anti-inflammatory agent on indomethacin-induced gastric ulcers in obese rats. · PeerJ
- 4.PMID: 38869599 (2024) — Comparative Study of Callistemon citrinus (Bottlebrush) and Punica granatum (Pomegranate) Extracts for Sustainable Synthesis of Silver Nanoparticles and Their Oral Antimicrobial Efficacy. · Nanomaterials (Basel, Switzerland)
- 5.PMID: 34435594